TomoTherapy (Madison, Wisconsin) said that co-founder Paul Reckwerdt will retire as president and relinquish his board directorship effective Dec. 31. Reckwerdt plans to pursue entrepreneurial opportunities and will serve as a strategic advisor to Compact Particle Acceleration Corp. (CPAC), which is developing a compact proton therapy system in partnership with TomoTherapy. Reckwerdt co-founded TomoTherapy in 1997 with Rock Mackie, PhD, to commercialize a highly precise form of radiation therapy that the two pioneered as researchers at University of Wisconsin. Fred Robertson, MD, has been named by the TomoTherapy board and will assume the role of president, in addition to his current role of CEO. TomoTherapy makes the Hi Art treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers.